{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,31]],"date-time":"2024-07-31T18:34:57Z","timestamp":1722450897385},"reference-count":23,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["jgaronline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Global Antimicrobial Resistance"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1016\/j.jgar.2014.06.004","type":"journal-article","created":{"date-parts":[[2014,7,23]],"date-time":"2014-07-23T20:18:20Z","timestamp":1406146700000},"page":"239-244","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Optimal duration of antimicrobial therapy in ventilator-associated pneumonia: What is the role for procalcitonin?"],"prefix":"10.1016","volume":"2","author":[{"given":"Marilia Rita","family":"Pinzone","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno","family":"Cacopardo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lilian","family":"Abbo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Nunnari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jgar.2014.06.004_bib0005","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1086\/501795","article-title":"Nosocomial infections in combined medical\u2013surgical intensive care units in the United States","volume":"21","author":"Richards","year":"2000","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.jgar.2014.06.004_bib0010","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1001\/jama.2009.1754","article-title":"International study of the prevalence and outcomes of infection in intensive care units","volume":"302","author":"Vincent","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.jgar.2014.06.004_bib0015","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1164\/rccm.200405-644ST","article-title":"Infectious Diseases Society of America Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia","volume":"171","author":"American Thoracic Society","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jgar.2014.06.004_bib0020","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1164\/ajrccm.165.7.2105078","article-title":"Ventilator-associated pneumonia","volume":"165","author":"Chastre","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jgar.2014.06.004_bib0025","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1378\/chest.122.6.2115","article-title":"Epidemiology and outcomes of ventilator-associated pneumonia in a large US database","volume":"122","author":"Rello","year":"2002","journal-title":"Chest"},{"key":"10.1016\/j.jgar.2014.06.004_bib0030","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1164\/ajrccm.156.1.9607030","article-title":"The value of routine microbial investigation in ventilator-associated pneumonia","volume":"156","author":"Rello","year":"1997","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jgar.2014.06.004_bib0035","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1378\/chest.115.2.462","article-title":"Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients","volume":"115","author":"Kollef","year":"1999","journal-title":"Chest"},{"key":"10.1016\/j.jgar.2014.06.004_bib0040","doi-asserted-by":"crossref","first-page":"621","DOI":"10.7326\/0003-4819-132-8-200004180-00004","article-title":"Invasive and noninvasive strategies for management of suspected ventilator-associated pneumonia. A randomized trial","volume":"132","author":"Fagon","year":"2000","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jgar.2014.06.004_bib0045","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1164\/ajrccm.163.6.2007020","article-title":"Resolution of infectious parameters after antimicrobial therapy in patients with ventilator-associated pneumonia","volume":"163","author":"Dennesen","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jgar.2014.06.004_bib0050","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1007\/s00134-007-0984-5","article-title":"Effects of systemic antibiotic therapy on bacterial persistence in the respiratory tract of mechanically ventilated patients","volume":"34","author":"Visscher","year":"2008","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.jgar.2014.06.004_bib0055","doi-asserted-by":"crossref","first-page":"2588","DOI":"10.1001\/jama.290.19.2588","article-title":"Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: a randomized trial","volume":"290","author":"Chastre","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.jgar.2014.06.004_bib0060","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s00134-008-1336-9","article-title":"European HAP Working Group Defining, treating and preventing hospital acquired pneumonia: European perspective","volume":"35","author":"Torres","year":"2009","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.jgar.2014.06.004_bib0065","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.annfar.2008.10.021","article-title":"Duration of antibiotic therapy for ventilator-associated pneumonia: comparison of 7 and 10 days. A pilot study","volume":"28","author":"Fekih Hassen","year":"2009","journal-title":"Ann Fr Anesth Reanim"},{"key":"10.1016\/j.jgar.2014.06.004_bib0070","series-title":"47th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC)","article-title":"Antibiotic treatment for the ventilator-associated pneumonia: 8 vs. 12 days randomized trial preliminary data","author":"Medina","year":"2007"},{"key":"10.1016\/j.jgar.2014.06.004_bib0075","doi-asserted-by":"crossref","first-page":"e41290","DOI":"10.1371\/journal.pone.0041290","article-title":"Early-onset ventilator-associated pneumonia in adults randomized clinical trial: comparison of 8 versus 15 days of antibiotic treatment","volume":"7","author":"Capellier","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jgar.2014.06.004_bib0080","series-title":"American Thoracic Society International Conference","article-title":"Procalcitonin (PCT) guided antibiotic treatment in ventilator associated pneumonia (VAP) Multicentre, clinical prospective, randomized-controlled study","author":"Pontet","year":"2007"},{"key":"10.1016\/j.jgar.2014.06.004_bib0085","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1183\/09031936.00053209","article-title":"Procalcitonin for reduced antibiotic exposure in ventilator-associated pneumonia: a randomized study","volume":"34","author":"Stolz","year":"2009","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jgar.2014.06.004_bib0090","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0140-6736(09)61879-1","article-title":"PRORATA Trial Group Use of procalcitonin to reduce patients\u2019 exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial","volume":"375","author":"Bouadma","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.jgar.2014.06.004_bib0095","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1378\/chest.125.5.1791","article-title":"A randomized controlled trial of an antibiotic discontinuation policy for clinically suspected ventilator-associated pneumonia","volume":"125","author":"Micek","year":"2004","journal-title":"Chest"},{"key":"10.1016\/j.jgar.2014.06.004_bib0100","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1164\/ajrccm.162.2.9909095","article-title":"Short-course empiric antibiotic therapy for patients with pulmonary infiltrates in the intensive care unit. A proposed solution for indiscriminate antibiotic prescription","volume":"162","author":"Singh","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"issue":"10","key":"10.1016\/j.jgar.2014.06.004_bib0105","first-page":"CD007577","article-title":"Short-course versus prolonged-course antibiotic therapy for hospital-acquired pneumonia in critically ill adults","author":"Pugh","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jgar.2014.06.004_bib0110","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1378\/chest.13-0076","article-title":"Short- vs long-duration antibiotic regimens for ventilator-associated pneumonia: a systematic review and meta-analysis","volume":"144","author":"Dimopoulos","year":"2013","journal-title":"Chest"},{"key":"10.1016\/j.jgar.2014.06.004_bib0115","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.hrtlng.2010.11.003","article-title":"Biomarkers for ventilator-associated pneumonia: review of the literature","volume":"40","author":"Palazzo","year":"2011","journal-title":"Heart Lung"}],"container-title":["Journal of Global Antimicrobial Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213716514000733?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213716514000733?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T11:29:20Z","timestamp":1538393360000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213716514000733"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":23,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["S2213716514000733"],"URL":"https:\/\/doi.org\/10.1016\/j.jgar.2014.06.004","relation":{},"ISSN":["2213-7165"],"issn-type":[{"value":"2213-7165","type":"print"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Optimal duration of antimicrobial therapy in ventilator-associated pneumonia: What is the role for procalcitonin?","name":"articletitle","label":"Article Title"},{"value":"Journal of Global Antimicrobial Resistance","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jgar.2014.06.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 International Society for Chemotherapy of Infection and Cancer. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}